V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009937 | 280010386 | 1.74 | 59.6 | Curative (C) | 2017-10-28 | 2018-01-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 280025364 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009938 | 280004997 | null | 21.8 | Palliative (P) | 2015-08-29 | 2015-10-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025366 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009939 | 280005000 | 1.85 | 86.7 | Palliative (P) | 2018-08-24 | 2018-09-22 | Docetaxel + Gemcitabine with GCSF | 02 | N | 280025368 | DOCETAXEL + GEMCITABINE |
| 280009940 | 280005001 | null | 66.6 | Curative (C) | 2013-08-18 | 2013-09-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025369 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009941 | 280011248 | 0.97 | 61 | Adjuvant (A) | null | 2015-12-20 | EW EuroEwing 2012 Arm B VC | Y | N | 280025380 | NOT MATCHED |
| 280009942 | 280005004 | null | 60.2 | Curative (C) | 2017-11-16 | 2017-11-17 | EW EuroEwing 2012 Arm B VC | N | Y | 280025382 | NOT MATCHED |
| 280009943 | 280005007 | 1.79 | 69 | Palliative (P) | 2015-02-18 | 2015-02-18 | Docetaxel + Gemcitabine with GCSF | N | N | 280025388 | DOCETAXEL + GEMCITABINE |
| 280009944 | 280011249 | null | 10.8 | Neo-adjuvant (N) | 2015-08-19 | 2015-08-19 | STS Rhabdo VIT0910 Vinc Irino Temoz | 2 | null | 280025391 | NOT MATCHED |
| 280009945 | 280005008 | 1.71 | 9.8 | Neo-adjuvant (N) | 2013-02-12 | 2013-04-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025394 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009946 | 280008652 | null | null | Palliative (P) | 2014-02-27 | 2014-04-14 | Cetuximab 7 day (>Cycle 2) | 02 | null | 280025395 | CETUXIMAB |
| 280009947 | 280005013 | 1.64 | 70.2 | Neo-adjuvant (N) | 2017-08-16 | 2018-02-01 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280025407 | DOCETAXEL + GEMCITABINE |
| 280009948 | 280005013 | 1.63 | 59.4 | Curative (C) | 2016-11-16 | 2017-03-12 | CARBOPLATIN | N | Y | 280025407 | CARBOPLATIN |
| 280009949 | 280005018 | 1.66 | 81.6 | Palliative (P) | 2015-02-17 | 2015-04-07 | Cetuximab 7 day (>Cycle 2) | 01 | N | 280025421 | CETUXIMAB |
| 280009950 | 280010393 | 1.53 | 74.4 | Not known (9) | 2017-11-13 | 2017-12-11 | Carboplatin AUC 2 - 5 | null | null | 280025422 | CARBOPLATIN |
| 280009951 | 280005020 | 1.7 | 66.4 | Adjuvant (A) | 2017-06-16 | 2017-06-25 | Cetuximab 7 day (>Cycle 2) | null | null | 280025423 | CETUXIMAB |
| 280009952 | 280005021 | null | null | Curative (C) | 2017-04-18 | 2017-05-16 | Cetuximab 7 day (>Cycle 2) | N | N | 280025424 | CETUXIMAB |
| 280009953 | 280005023 | null | null | Palliative (P) | 2015-05-31 | 2015-05-31 | Docetaxel+Gemcitabine (no prior RT) | Y | N | 280025425 | DOCETAXEL + GEMCITABINE |
| 280009954 | 280005026 | null | 90.1 | Palliative (P) | 2013-08-15 | 2013-09-06 | EW Rel rEECur Gemcitabine/Docetaxel | N | Y | 280025426 | NOT MATCHED |
| 280009955 | 280008659 | 1.8 | null | Curative (C) | 2014-05-22 | 2014-06-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025427 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009956 | 280005032 | 1.65 | 67.7 | Palliative (P) | 2016-06-15 | 2016-06-15 | Docetaxel + Gemcitabine with GCSF | N | N | 280025444 | DOCETAXEL + GEMCITABINE |
| 280009957 | 280005034 | null | 90.1 | Palliative (P) | 2017-11-04 | 2017-11-17 | CETUXIMAB | Y | N | 280025446 | CETUXIMAB |
| 280009958 | 280008663 | null | 68.9 | null | 2014-06-24 | 2014-06-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 280025447 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009959 | 280005036 | null | 66.1 | Adjuvant (A) | 2015-11-17 | 2016-01-15 | Carboplatin AUC 6 - 10 | null | null | 280025450 | CARBOPLATIN |
| 280009960 | 280005037 | 0 | 98 | Curative (C) | 2016-03-27 | 2016-08-27 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | 280025454 | NOT MATCHED |
| 280009961 | 280005039 | null | 70.2 | Palliative (P) | 2013-05-12 | 2013-06-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 01 | N | 280025456 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009962 | 280008667 | 0 | 55.3 | Neo-adjuvant (N) | 2017-04-17 | 2017-08-05 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | null | 280025459 | NOT MATCHED |
| 280009963 | 280005044 | 0 | 56.8 | Palliative (P) | null | 2014-07-19 | EW EuroEwing 2012 Arm A VAC | N | N | 280025465 | NOT MATCHED |
| 280009964 | 280010398 | null | 65.6 | Palliative (P) | 2019-04-11 | 2019-04-11 | Docetaxel + Gemcitabine (prior RT) | N | N | 280025465 | DOCETAXEL + GEMCITABINE |
| 280009965 | 280008669 | 1.58 | 62.7 | Palliative (P) | null | 2018-03-08 | Carboplatin AUC 2 - 5 | N | N | 280025471 | CARBOPLATIN |
| 280009966 | 280005046 | 0 | 72 | Palliative (P) | 2016-07-12 | 2016-07-17 | EW EuroEwing 2012 Arm B VC | 02 | Y | 280025472 | NOT MATCHED |
| 280009967 | 280008670 | 1.8 | null | Palliative (P) | null | 2015-07-12 | DOCETAXEL + GEMCITABINE | 2 | N | 280025479 | DOCETAXEL + GEMCITABINE |
| 280009968 | 280008671 | null | 74.4 | Palliative (P) | null | 2018-06-18 | Cetuximab 7 day (>Cycle 2) | Y | N | 280025489 | CETUXIMAB |
| 280009969 | 280005050 | 1.55 | 52.1 | Palliative (P) | 2015-05-13 | 2015-06-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025499 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009970 | 280005051 | null | null | null | 2016-09-15 | 2016-09-15 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | 280025504 | NOT MATCHED |
| 280009971 | 280010403 | 1.88 | 89 | Disease modification (D) | 2015-03-02 | 2015-04-21 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280025505 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009972 | 280008675 | 1.74 | 8.4 | Curative (C) | 2016-05-15 | 2016-05-29 | CETUXIMAB | null | null | 280025510 | CETUXIMAB |
| 280009973 | 280011257 | null | null | Palliative (P) | 2016-06-04 | 2016-09-10 | CARBOPLATIN | N | Y | 280025512 | CARBOPLATIN |
| 280009974 | 280005057 | 1.8 | null | Palliative (P) | 2016-12-09 | 2016-12-09 | Carboplatin AUC 6 - 10 | N | N | 280025512 | CARBOPLATIN |
| 280009975 | 280005057 | 1.9 | 81.2 | Palliative (P) | null | 2016-10-30 | Carboplatin AUC 6 - 10 | 02 | N | 280025512 | CARBOPLATIN |
| 280009976 | 280005059 | 1.7 | 106.4 | Neo-adjuvant (N) | 2016-09-18 | 2017-06-25 | null | 02 | N | 280025519 | NOT MATCHED |
| 280009977 | 280005061 | 1.69 | 18.3 | Palliative (P) | 2017-01-22 | 2017-06-06 | Docetaxel + Gemcitabine (prior RT) | null | null | 280025521 | DOCETAXEL + GEMCITABINE |
| 280009978 | 280005062 | null | 75 | Palliative (P) | 2016-01-23 | 2016-02-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025522 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009979 | 280008681 | 2 | 57.9 | Curative (C) | 2015-02-01 | 2015-02-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025524 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009980 | 280005066 | 1.9 | 112 | Curative (C) | 2013-12-08 | 2014-01-31 | Carboplatin AUC 2 - 5 | 02 | N | 280025525 | CARBOPLATIN |
| 280009981 | 280005069 | null | 74 | Neo-adjuvant (N) | 2015-08-07 | 2015-09-24 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025532 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009982 | 280008685 | 1.64 | 107.6 | Palliative (P) | 2018-06-23 | 2018-12-04 | Cetuximab 7 day (>Cycle 2) | N | N | 280025533 | CETUXIMAB |
| 280009983 | 280005072 | 1.79 | 69.4 | Palliative (P) | 2016-03-11 | 2016-08-12 | null | N | N | 280025541 | NOT MATCHED |
| 280009984 | 280005075 | null | 74.4 | Palliative (P) | null | 2018-06-27 | null | N | null | 280025545 | NOT MATCHED |
| 280009985 | 280005077 | 1.61 | 64.9 | Palliative (P) | 2015-09-21 | 2015-10-31 | Cetuximab 7 day (>Cycle 2) | N | N | 280025546 | CETUXIMAB |
| 280009986 | 280005080 | null | null | Palliative (P) | 2018-12-18 | 2018-12-18 | WT SIOP 2002 01 post op Carbo, Etop | 02 | N | 280025551 | NOT MATCHED |